Skip to main content

Peer Review reports

From: Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

Original Submission
12 Apr 2012 Submitted Original manuscript
26 Jun 2012 Reviewed Reviewer Report - Alessandro Comandone
12 Nov 2012 Reviewed Reviewer Report - Mark Linch
29 Jan 2013 Author responded Author comments - Conrad Messam
Resubmission - Version 2
29 Jan 2013 Submitted Manuscript version 2
8 Feb 2013 Author responded Author comments - Conrad Messam
Resubmission - Version 3
8 Feb 2013 Submitted Manuscript version 3
Publishing
6 Mar 2013 Editorially accepted
16 Mar 2013 Article published 10.1186/1471-2407-13-121

You can find further information about peer review here.

Back to article page